The path to adoption of open source AI for drug discovery in Africa

The path to adoption of open source AI for drug discovery in Africa

Saved in:

Bibliographic Details
Main Authors:	Gemma Turon, Miquel Duran-Frigola
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Series:	Artificial Intelligence in the Life Sciences
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667318524000254
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Adoption of Open Source Software Among Universities in Iraq: The Moderating Role of AI Capability
by: Mustafa Moosa Qasim, et al.
Published: (2025-01-01)

kMoL: an open-source machine and federated learning library for drug discovery
by: Romeo Cozac, et al.
Published: (2025-02-01)

Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.
by: Wesley C Van Voorhis, et al.
Published: (2016-07-01)

From Code to Concept: A Semantic Approach to AI Innovation Discovery in Open Source Software Repositories
by: Inna Novalija, et al.
Published: (2025-01-01)

A data-driven framework for predicting solar rooftop adoption in Germany based on open-source data
by: Kaan Duran, et al.
Published: (2025-07-01)

AI-Driven Drug Discovery: A Comprehensive Review
by: Fábio J. N. Ferreira, et al.
Published: (2025-06-01)

Editorial: Allergies and anti-allergy drug discovery in Africa
by: Sabelo Hadebe, et al.
Published: (2025-04-01)

Recent advances in AI-based toxicity prediction for drug discovery
by: Hyundo Lee, et al.
Published: (2025-07-01)

Generative AI for drug discovery and protein design: the next frontier in AI-driven molecular science
by: Uddalak Das
Published: (2025-09-01)

AI-driven discovery of synergistic drug combinations against pancreatic cancer
by: Mohsen Pourmousa, et al.
Published: (2025-04-01)

The application of the open pharmacological concepts triple store (open PHACTS) to support drug discovery research.
by: Joseline Ratnam, et al.
Published: (2014-01-01)

Advancing open education through open-source software: examining UTAUT 2 factors in adoption and implementation
by: Chenggui Duan
Published: (2024-11-01)

Open Source HBIM and OpenAI: Review and New Analyses on LLMs Integration
by: Filippo Diara
Published: (2025-04-01)

Integration of AI and ML in Tuberculosis (TB) Management: From Diagnosis to Drug Discovery
by: Sameeullah Memon, et al.
Published: (2025-06-01)

AI and Generative AI for Research Discovery and Summarization
by: Mark Glickman, et al.
Published: (2024-04-01)

Is Open Source the Future of AI? A Data-Driven Approach
by: Domen Vake, et al.
Published: (2025-03-01)

How AI sources can increase openness to opposing views
by: Louise Lu, et al.
Published: (2025-05-01)

Measuring Attitudes toward Open Adoption: Spanish Validation of the Open Adoption Scale
by: Ana Berástegui, et al.
Published: (2025-02-01)

DMCCB Basel Symposium 2024: Therapeutics by Computational Design: Innovations in Drug Discovery and AI
by: Simon R. Williams
Published: (2024-08-01)

Open access target validation is a more efficient way to accelerate drug discovery.
by: Wen Hwa Lee
Published: (2015-06-01)

The Discovery Power of Staying Open
by: Judith A. Holton
Published: (2017-06-01)

Small, open-source text-embedding models as substitutes to OpenAI models for gene analysis
by: Dailin Gan, et al.
Published: (2025-01-01)

Fields2Benchmark: An open-source benchmark for coverage path planning methods in agriculture
by: Gonzalo Mier, et al.
Published: (2025-12-01)

AI-driven drug discovery and repurposing using multi-omics for myocardial infarction and heart failure
by: Ziad Sabry, et al.
Published: (2025-06-01)

Adjusted imbalance ratio leads to effective AI-based drug discovery against infectious disease
by: Ons Masmoudi, et al.
Published: (2025-08-01)

Revolutionize 3D-Chip Design With Open3DFlow, an Open-Source AI-Enhanced Solution
by: Yifei Zhu, et al.
Published: (2025-01-01)

From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes
by: Doni Dermawan, et al.
Published: (2025-06-01)

Harnessing AI and Quantum Computing for Revolutionizing Drug Discovery and Approval Processes: Case Example for Collagen Toxicity
by: David Melvin Braga, et al.
Published: (2025-07-01)

Network Pharmacology-Driven Sustainability: AI and Multi-Omics Synergy for Drug Discovery in Traditional Chinese Medicine
by: Lifang Yang, et al.
Published: (2025-07-01)

Conformational Space Profiling Enhances Generic Molecular Representation for AI‐Powered Ligand‐Based Drug Discovery
by: Lin Wang, et al.
Published: (2024-10-01)

Computer-Aided Drug Design and Drug Discovery
by: Dragos Paul Mihai, et al.
Published: (2025-03-01)

Discovery of effective infrequent sequences based on maximum probability path
by: Ke Lu, et al.
Published: (2022-12-01)

Detecting similar binding pockets to enable systems polypharmacology.
by: Miquel Duran-Frigola, et al.
Published: (2017-06-01)

Enabling AI Adoption through Assurance
by: Jaganmohan Chandrasekaran, et al.
Published: (2022-05-01)

Modern Foreign Approaches to Open Adoption
by: Y.F. Chinareva
Published: (2025-06-01)

Nanobodies: From Discovery to AI-Driven Design
by: Haoran Zhu, et al.
Published: (2025-05-01)

AI for food: accelerating and democratizing discovery and innovation
by: Ellen Kuhl
Published: (2025-05-01)

From Molecules to Medicines: The Role of AI-Driven Drug Discovery Against Alzheimer’s Disease and Other Neurological Disorders
by: Mashael A. Alghamdi
Published: (2025-07-01)

Evaluating Critical Success Factors in AI-Driven Drug Discovery Using AHP: A Strategic Framework for Optimization
by: Amir Mohamed Talib, et al.
Published: (2025-01-01)

AI drug discovery tools and analysis technology: New methods aid in studying the compatibility of Traditional Chinese Medicine
by: Qiwu Jiang, et al.
Published: (2025-03-01)